Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBE-IPL-MGX for Evaporative Dry Eye
NCT05857579Completed
- Sponsor
- University of Seville
- Start
- Apr 2022
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in dry eye disease (DED) and meibomian gland dysfunction (MGD), sponsored by University of Seville. Primary endpoints: Ocular Surface Disease Index at 8 weeks, Tear Meniscus Height at 8 weeks and 1 more. Started Apr 2022; status: completed.
02
Conditions
dry eye disease (DED)meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NCT05857579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05857579.